[1] |
WANG Haodi, DENG Zhengming, WANG Gang, JIANG Zhiwei.
Disease burden in colorectal cancer attributed to fasting hyperglycemia in china from 1990 to 2021 and projections of future trends
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 61-67.
|
[2] |
CAO Le, MA Minmin, LI Wenmin, SHUI Mingming, JIANG Cheng.
Trend of mortality and disease burden of gastric cancer in China,2004—2021
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 68-73.
|
[3] |
ZHONG Wuning, KANG Wei, WANG Zhonghai, ZHAO Xin, SU Danke.
Correlation between come beam breast computed tomography features and HER2 expression in non⁃mass enhancement breast cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(4): 429-434.
|
[4] |
QIU Lin, TONG Yang, JIN Yongmei.
Evidence for sexual health management of breast cancer patients
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(4): 434-439.
|
[5] |
Jin Mingpeng,Yin Chun,Shang Yingying,Cao Haiyan,Ji Xiaoying,Ren Tingting,Xing Jinliang,Wu Yousheng.
Effect of NCLX-mediated mitochondrial calcium homeostasis on the growth of hepatocellular carcinoma cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(6): 420-426.
|
[6] |
Zhao Lingyun,You Xuemei,Wei Jueling,Zhao Xinhua,Tang Juan,Li Qiuqin,Luo mei.
Effect of short-term structural psychological education intervention combined with Xiaoyaosan on moderate and severe depression in patients with hepatocellular carcinoma during periop-erative period
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(6): 473-478.
|
[7] |
Tan Ni,Cao Ji,Yang Chun,Zheng Haiping,Ou Chao.
Analysis of the alternative splicing events of AFB1-induced liver cancer in rats based on RNA-seq
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(5): 356-360.
|
[8] |
Wu Linghong,Huang Tianren,Deng Wei,Huang Zhibi,Guo Jiao,Huang Yueying.
Meta-analysis:the relationship of hepatitis B virus genotypes,subgenotypes and hepato-cellular carcinoma in China
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(5): 365-370.
|
[9] |
Ni Lu,Zhao Zhiqiang,Gao Yue,Mu Hanzheng,Qi Yunfei.
Effect of FOXK1 on the invasion and migration of hepatocellular carcinoma cell line Huh7
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(4): 286-289.
|
[10] |
Tan Baogao,Liu Biao.
The value of 3.0T MR arterial spin labeling in the diagnosis of early-stage primary liver cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(4): 310-313.
|
[11] |
Jiang Qunxiang,Wei Feifei,Wang Hongxue,Guo Hui,Xie Yu'an.
Relationships between polymorphism in the growth hormone receptor gene and risk of hepatocellular carcinoma in families of Fusui County,Guangxi
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(3): 205-208.
|
[12] |
He Pan,Fan Ni,Chen Si,Tang Yanping,Li Kezhi,Yang Chun,Huang Xiaoqing,Cao Ji.
Expression of APOF and IGFALS in primary hepatocellular carcinoma and its clinical significance
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(3): 212-215.
|
[13] |
Wang Jianwu, Yu Xiangyuan, Wang Qianqian, Qin Linyuan, Bei Chunhua,Tan Shengkui, He Songqing, Tang Bo, Liao Weijia, Yu Hongping.
Single nucleotide polymorphisms in DNA repair gene RAD52 miRNA target sequence and susceptibility to hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(2): 99-104.
|
[14] |
Ou'yang Gaoxiong, Zhang Zhiming,Wang Peng,Ren Yuan,Li Jiahao,Liu Yukai, Xiang Bangde, Liu Jianyong.
Ratio of gamma-glutamyl transpeptidase to platelets for staging hepatic fibrosis in patients with hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(2): 119-123.
|
[15] |
Zhang Jie,Xu Jing,Li Zihui,Wu Feixiang,Zou Ling,Chen Jie,Ye Jiazhou,Mo Xianwei,Li Lequn,Lin Yuan,Liang Lisheng.
Implementation of the total care and treatment model in the diagnosis and treatment of hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(1): 47-51.
|